Name
mxcanop3
Label
Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Units
seconds
Type
numeric
Sleep Heart Health Study (SHHS) Visit Number vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | 923 | 21.3 | ± 8.1 | 19.0 | 10.0 | 85.0 | 4,881 | 5,804 |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | 512 | 19.9 | ± 8.1 | 18.0 | 10.0 | 71.0 | 3,568 | 4,080 |
| CVD Outcomes | - | - | - | - | - | - | - | - |
Age at Sleep Heart Health Study Visit One (SHHS1) vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 923 | 21.3 | ± 8.1 | 19.0 | 10.0 | 85.0 | 4,881 | 5,804 |
| 35-44 years | 44 | 19.2 | ± 6.7 | 17.0 | 11.0 | 40.0 | 298 | 342 |
| 45-54 years | 128 | 18.8 | ± 6.3 | 18.0 | 10.0 | 41.0 | 889 | 1,017 |
| 55-64 years | 279 | 19.8 | ± 6.9 | 18.0 | 10.0 | 43.0 | 1,490 | 1,769 |
| 65-74 years | 284 | 21.3 | ± 8.3 | 19.0 | 10.0 | 85.0 | 1,333 | 1,617 |
| 75-84 years | 173 | 25.4 | ± 9.6 | 23.0 | 11.0 | 64.0 | 782 | 955 |
| 85 years or older | 15 | 26.3 | ± 7.2 | 26.0 | 13.0 | 37.0 | 89 | 104 |
Gender of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 923 | 21.3 | ± 8.1 | 19.0 | 10.0 | 85.0 | 4,881 | 5,804 |
| Male | 630 | 22.4 | ± 8.5 | 20.0 | 10.0 | 85.0 | 2,135 | 2,765 |
| Female | 293 | 18.8 | ± 6.6 | 18.0 | 10.0 | 64.0 | 2,746 | 3,039 |
Gender of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 512 | 19.9 | ± 8.1 | 18.0 | 10.0 | 71.0 | 3,568 | 4,080 |
| Male | 354 | 20.7 | ± 8.5 | 19.0 | 10.0 | 71.0 | 1,507 | 1,861 |
| Female | 158 | 18.2 | ± 6.6 | 17.0 | 10.0 | 54.0 | 2,061 | 2,219 |
Race of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 923 | 21.3 | ± 8.1 | 19.0 | 10.0 | 85.0 | 4,881 | 5,804 |
| White | 797 | 21.5 | ± 8.4 | 19.0 | 10.0 | 85.0 | 4,110 | 4,907 |
| Black | 71 | 20.3 | ± 6.1 | 19.0 | 11.0 | 38.0 | 444 | 515 |
| Other | 55 | 19.7 | ± 6.7 | 19.0 | 10.0 | 41.0 | 327 | 382 |
Race of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 512 | 19.9 | ± 8.1 | 18.0 | 10.0 | 71.0 | 3,568 | 4,080 |
| White | 463 | 20.0 | ± 8.1 | 18.0 | 10.0 | 71.0 | 3,124 | 3,587 |
| Black | 28 | 20.0 | ± 5.9 | 18.5 | 12.0 | 35.0 | 228 | 256 |
| Other | 21 | 19.1 | ± 9.5 | 16.0 | 11.0 | 49.0 | 216 | 237 |